Page 11234..10..»

Category : Nanomedicine

Top Nanotechnology Conferences | Top Nanomedicine …

Sessions/Tracks

Pharma Nano 2018-USA is a global annual event. This Pharma Nano 2018-USA brings together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. The passage of approval for Nano Medicine finds much requirement for discussion also focussing the latest developments in the field of Nano Medicine and Nanoparticles

Theme: Breakthroughs in Pharmaceutical Nanotechnology: Advancements and Challenges.

Track 1: Nanoparticles and Nanomedicine

Nanomedicineis a branch of medicine that applies the knowledge and tools of nanotechnology in the prevention and treatment of diseases. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nano robots, for diagnosis, delivery, sensing or actuation purposes in a living organism. Nanoparticles from 1-100 nm have been widely used to improve the drug accumulation, internalization and therapeutic efficacy. The physicochemical and biological properties of the nanoparticles can also be finely adjusted by tailoring their chemical properties, sizes, shapes, structures, morphologies, and surface properties. Nanomedicine is the medical application of nanotechnology. Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials.

Track 2: The Evolution of Nanomedicine with the Re-Evolution of Nanotechnology

Nanotechnology seems to have gained a widespread interest in the recent years. Nanotechnology has considerably accelerated the growth of regenerative medicine in the past few years. Application of nanotechnology in regenerative medicine has revolutionized the designing of grafts and scaffolds which has resulted in new grafts/scaffold systems having significantly enhanced cellular and tissue regenerative properties. Since the cellcell and cell-matrix interaction in biological systems takes place at the nanoscale level, the application of nanotechnology gives an edge in modifying the cellular function and/or matrix function in a more desired way to mimic the native tissue/organ. Nanomedicine introduces nanotechnology concepts into medicine and thus joins two large cross disciplinary fields with an unprecedented societal and economical potential arising from the natural combination of specific achievements in the respective fields.

Track 3: Computational Studies in Nanoparticles

The computational studies in nanoparticles have demonstrated that there has been considerable progress in nano- and biotechnologyinthe last several years. However, several key challenges have also become apparent, including the need for a better understanding of nanoparticle behaviour in vivo and the development of more effective nanoparticle therapeutics. Computational efforts are becoming an important tool in addressing both of these challenges, as well as in generally facilitating and accelerating nanotechnology-based translational research. The nanoinformatics has comes out as a new research area that covers raw data management, analysis of the data derived from biomedical applications and simulation of nanoparticle interactions with biological systems depicting the integration of biology, nanotechnology and informatics to form the basis for computational nanomedicine.

Track 4: Toxicology of Nanoparticles

Nanotechnology is a rapidly growing field having potential applications in many areas. Nanoparticles have been studied for cell toxicity, immunotoxicity, and genotoxicity. Tetrazolium-based assays such as MTT, MTS, and WST-1 are used to determine cell viability. Different types of cell cultures, including cancer cell lines have been employed as in vitro toxicity models. Considering the potential applications of NPs in many fields and the growing apprehensions of FDA about the toxic potential of nanoproducts, it is the need of the hour to look for new internationally agreed free of bias toxicological models by focusing more on in vivo studies. The rapid expansion of nanotechnology promises to have great benefits for society, yet there is increasing concern that human and environmental exposure to engineered nanomaterials may result in significant adverse effects. The system was developed for nanotoxicity assessment at single and multiple cell levels which can measure and compare the microscopic and macroscopic effects of nanoparticles interaction with cells, without interference from neighbour ing cells’ cues and also overall integrative effects produced by nanoparticles and cellcell communication.

Track 5: Emerging Nanomedicine

Currently, the treatment of HIV requires daily regular oral dosage of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies. Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.

In a four-year study conducted on the mouse model in advanced breast cancer metastasis in the eye’s anterior chamber, the new nanoparticle not only killed tumour cells in the eye, but also extended the survival of experimental mice bearing 4T1 tumors, a cell line that is extremely difficult to kill. “Previous monotherapies have not extended the lifetimes of mice bearing this type of tumour”.

Track 6: Smart Drug Delivery Technology

Some smart drug delivery platform is based on neutral phospholipid nanoliposomes. Classic liposomes modalities have had manufacturing problems involving sizing, uniformity, loading, storage, and enhancement compatibility, which can be overcome by employing true nanotechnology to build liposomes upon discrete self-assembling DNA scaffolds. The smart drug delivery system is used for delivering drugs to the host. Biological information detected by biological sensors is analyzed and the drug delivery system is actuated to deliver the drug based on the information. MEMS or NEMS technology based drug pumps, micro-pumps, micro-needles, micro-osmotic pumps, and nano-pumps are utilized for smarter drug delivery. One of the concerns these days about self-assembling nanotechnology is that it is so advanced beyond the current drug paradigm that it becomes problematic from a regulatory point of view. While there is currently no drug treatment delivered directly into these types of cancers.

Track 7: Design and Characterization of Nano Drug Systems

Recent years have witnessed the rapid development of inorganic nanomaterials for medical applications. At present, nanomedicines-nanoparticles (NPs) destined for therapy or diagnosis purposes-can be found in a number of medical applications, including therapeutics and diagnosis agents. Pushing the limits of nanotechnology towards enhanced nanomedicines will surely help to reduce side effects of traditional treatments and to achieve earlier diagnosis. The interplay between engineered nanomaterials and biological components is influenced by complex interactions which make predicting their biological fate and performance a nontrivial issue. We hope that both early-stage and experienced researchers will find it valuable for designing nanoparticles for enhanced bio-performance. Nanoemulsions have attracted great attention in research, dosage form design and pharmacotherapy. This is as a result of a number of attributes peculiar to nanoemulsions.

Track 8: Nanoparticles as Precise Drug Delivery Systems

With the remarkable development of nanotechnology in recent years, new drug delivery approaches based on the state-of-the-art nanotechnology have been receiving significant attention. Nanoparticles, an evolvement of nanotechnology, are increasingly considered as a potential candidate to carry therapeutic agents safely into a targeted compartment in an organ, particular tissue or cell. These particles are colloidal structures with a diameter less than 1,000 nm, and therefore can penetrate through diminutive capillaries into the cells internal machinery. This innovative delivery technique might be a promising technology to meet the current challenges in drug delivery. The different types of nanoparticles drug delivery systems under investigation and their prospective therapeutic applications, and also present a closer look at the advances, current challenges, and future direction of nanoparticles drug delivery systems.

Track 9: Polymer Nanoparticles for Nanomedicines

The use of nanoscale materials and processes to address human diseases is perhaps the most promising, considering that most complex downstream symptoms of disease are initiated by molecular level phenomena. Nanomedicine is defined as biological and medical intervention at the nanometer scale for the treatment, diagnosis, and increased understanding of biology and disease. Tremendous advances in the area of polymer synthesis and self-assembly have given rise to a new toolbox of engineered nanosized delivery and diagnostic agents that permit systemic and local administration, circulation in the bloodstream, and uptake and diffusion at the cellular and subcellular level.

Track 10: Nano Medicine Industry and Market Analysis

Nano Medicine Industry and Market Analysis focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and the rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. The study The Global Nanomedicine Market is poised to grow at a CAGR of around 16.6% over the next decade to reach approximately $1.3 trillion by 2025.This industry report analyses the global markets for Nanomedicine across all the given segments on global as well as regional levels presented in the research scope.

Track 11: Research and Development of Nanomedicine

Nanomedicine has been developing rapidly in recent years, particularly in the development of novel nano tools for medical diagnosis and treatment. For instance, a new trend is becoming prevalent in developing nanosystems for simultaneous tumour diagnosis and therapy. A new terminology “theranostics” has been frequently used and applied in pre-clinical research and trials. A nanosystem can simultaneously achieve both cell targeted during in vivo imaging and photothermal treatment of cancer. While achieving concurrent high spatial and temporal resolution of the lesions via cell targeting; special non-evasive treatments are implemented at the same time by various means, such as localized drug release, hyperthermia, and photo-thermal therapy. Inspired by these challenging problems in biomedical fields, the development of the nanotechnologies will be the key in addressing some of the critical issues in medicine, especially in early cancer diagnosis and treatment.

Track 12: Nano Pharmaceutical Medicine

The term Nano became tantamount to cutting-edge and was quickly embraced by the pharmaceutical science community. The novel concept of nanomedicinegenerated as a result of a scientific amalgamation between nanoscience and nanotechnology with medicine. Pharmaceutical scientists quickly adopted nanoscience terminology, thus creating Nano pharmaceuticals. Moreover, just using the term nano intuitively implied state-of-the-art research and became very fashionable within the pharmaceutical science community. Formulation of Nano pharmaceuticals contain active extracts obtained from medicinal plants. In physiological conditions, the interactions between blood platelets and endothelial cells play a major role in vascular reactivity and haemostasis. In contrast, increased platelet activation contributes to the pathogenesis of vascular pathology such as atherosclerosis, thrombosis, diabetes mellitus, hypertension and carcinogenesis. The rapid developments in nanostructured materials and nanotechnology will have profound impact in many areas of biomedical applications including delivery of drugs and biomolecules, tissue engineering, detection of biomarkers, cancer diagnosis, cancer therapy and imaging.

Track 13: Nanoparticle Interaction

Particleparticle interactions in physiological media are important determinants for nanoparticle fate and transport. Herein, such interactions are assessed by a novel atomic force microscopy -based platform. Industry-relevant CeO2, Fe2O3, and SiO2 nanoparticles of various diameters were made by the flame spray pyrolysis (FSP)-based Harvard Versatile Engineering Nanomaterials Generation System (Harvard VENGES). The nanoparticles were fully characterized both structurally and morphologically, and their properties in water and biological media were also assessed. The nanoparticles were attached on AFM tips and deposited on Si substrates to measure particleparticle interactions. Nanoparticle interactions in solution affect their binding to biomolecules, their electronic properties, and their packing into larger crystals. However, the theories that describe larger colloidal particles fail for nanoparticles, because the interactions do not add together linearly. Nanoparticle interactions are often described by classical colloidal theories developed for Ps.

Track 14: Nanomedicine Ethical Issues

As the science and technology of nanomedicine speed ahead, ethics, policy, and the law struggle to catch up also chases after it. It is important to proactively address the ethical, social and regulatory aspects of nanomedicine to minimize its adverse impacts on the environment and public health and to avoid a public backlash. In the next 1015 years, nanotechnology is likely to revolutionize the practice of medicine and have a significant impact on human health. Nanotechnology is already contributing to the development of new drugs, biologics, and medical devices and the augmentation of existing therapeutics. Over 200 companies are involved in nanomedicine research and development. The U.S. Food and Drug Administration has approved nine different types of therapies that employ nanoscale materials, including products used for medical testing and imaging, drug delivery, wound healing, and bone and tissue repair. Discoveries and innovations in nanomedicine have occurred at a breath taking pace in just a short time, uses of nanotechnology in medicine have moved from laboratory testing, to clinical trials, to medical applications.

Track 15: Pharmaceutical Formulations

Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect. Formulation studies also consider such factors as particle size, polymorphism, pH, and solubility, as all of these can influence bioavailability and hence the activity of a drug. The drug must be combined with inactive ingredients by a method which ensures that the quantity of drug present is consistent in each dosage unit e.g. each tablet. The dosage should have a uniform appearance, with an acceptable taste, tablet hardness, or capsule disintegration. By the time phase III clinical trials are reached, the formulation of the drug should have been developed to be close to the preparation that will ultimately be used in the market.

Track 16: Applied Pharmaceutical Science

Pharmacy is the science and technique of preparing and dispensing drugs. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. A theory relating chemical structure to pharmaceutical activity emerged from the interplay of experimental results from animal and human tests using vaccines, antitoxins, and antibodies with chemical knowledge about dyes and their molecular structures. Although pharmacology is essential to the study of pharmacy, it is not specific to pharmacy. Pharmacoinformatics is considered as another new discipline, for systematic drug discovery and development with efficiency and safety. The progressively more important role of the chemist and chemical science in pharmaceuticals in the early-20th century is mirrored in the history of the American Chemical Society’s Division of Medicinal Chemistry.

International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine, (Pharma Nano 2018-USA) scheduled to be held during April 18-19, 2018 Las Vegas, USA. This Pharma Nano 2018 Conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. The conference invites delegates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Nano Medicine 2018 International conference will be an excellent opportunity to meet eminent personalities in the fields of pharmaceutics and learn about the latest technological advancements.

ConferenceSeries.com hosts 3000+ Global Events that includes over 600+ International Conferences, 1200+ Symposiums and 1200+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields.

Why to Attend???

Pharma Nano 2018-USA Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about Nano Medicine and its advances. This is your best opportunity to reach the largest assemblage of participants from Nano Medicine community that is from academia, research entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries.

Who should attend and Who Youll Meet

Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of

Pharma R&D

CROs and CMOs

Clinical Research Sites

Pharma/Biotech and Medical Device industries

Hospitals, Associations

Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals along with Academicians: University Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professor, Research Scholars, scientists who are related to clinical and medical research. Students also participate at this event as student delegates and young research forum (YRF).

See original here:
Top Nanotechnology Conferences | Top Nanomedicine …

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine – Official Site

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.

Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results…

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine.

Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases. In addition to bimonthly issues, the journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.

The potential scope of nanomedicine is broad, and we expect it to eventually involve all aspects of medicine. Sub-categories include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; regenerative medicine; public health; toxicology; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.

Article formats include Communications, Original Articles, Reviews, Perspectives, Technical and Commercialization Notes, and Letters to the Editor. We invite authors to submit original manuscripts in these categories. The journal website (http://www.nanomedjournal.com) also presents important nanomedicine-related information, such as future meetings, meeting summaries, funding opportunities, societal subjects, public health, and ethical issues of nanomedicine.

Read more:
Nanomedicine – Official Site

Recommendation and review posted by Alexandra Lee Anderson

What is Nanomedicine? The future of medicine.

Materials which have at least one dimension less than 100nm are classified as nanomaterials. These materials can be may shapes and sizes like spheres, rods, wires, cubes, plates, stars, cages, pyramids among some funny named shapes like nanohedgehogs, nanocandles and nanocakes! See the paperMorphology-Controlled Growth of ZnO Nanostructures Using Microwave Irradiation: from Basic to Complex Structuresfor some really inventive names for various shaped nanomaterials!

Aside scientists are pretty terrible at naming things, for example,the creative names given to optical telescopes the Extremely Large Telescope,Large Binocular Telescope,Overwhelmingly Large Telescope,Very Large Optical Telescope.

These nanoparticle shapes come in different sizes and different materials too. Broadly we can categorize nanomaterials into two groups organic or inorganic (but it is possible to have a hybrid inorganic-organic nanoparticle too). Organic nanoparticles arent nanoparticles from your local farmers market they are nanoparticles which contain carbon (and often hydrogen too which forms hydrocarbons) whereas most inorganic nanoparticles dont contain carbon atoms. Organic nanomaterials include carbon (except fullerenes) , polymeric and lipid-based nanocarriers. Inorganic nanoparticles include metallic/plasmonic, magnetic, upconversion, semiconductor and silica based nanoparticles.

The main groups of organic nanocarriers are liposomes, micelles, protein/peptide based and dendrimers. Protein/peptide based nanocarriers are amorphous (non-crystalline) materials generally conjugated to the therapeutic agent and is often further functionalised with other molecules. Micelles and liposomes are formed by amphiphilic (both hydrophilic and hydrophobic parts), micelles form monolayers whereas liposomes form bilayers. Lastly, dendrimer nanocarriers are tree-like structures which have a starting atom core (eg. nitrogen) and other elements are added through a series of chemical reactions resulting in a spherical branching structure. This final structure is not unlike blood hemoglobin and albumin macromolecules.

These vesicular nanocarriers can be used to trap both hydrophobic and hydrophilic drugs and even small nanoparticles inside the aqueous/lipid core. This provides protection for drugs and facilitates significant drug loading minimising toxicity and increasing blood circulation time (increasing possibility that the drug will reach the therapeutic target from avoiding opsonisation).

inorganic nanomaterials are stable, robust, resistant, highly functional. and are quite easily cleared from the body. Furthermore, inorganic material exhibit truly exciting mechanical, optical, physical and electrical phenomena at the nanoscale which can be tailored through changes in material, phase, shape, size and surface characteristics. Oftentimes, it is necessary to add a biocompatible surface to inorganic nanoparticles to avoid toxicity, especially for heavy metals.

Semiconductor Nanomaterials

Quantum dots are the most well-known semiconductor nanoemitter. These are typically very small in size ~5nm, which is smaller or equal to the exciton Bohr radius giving quantum confinement. Electrons are subatomic particles with a negative elementary electric charge, electron holes is an empty position in an atom or lattice that an electron could occupy. An exciton is a bound statewhere an electron and electron hole are electrostatically attracted to each other through Coulombic forces.Anexciton bohr radiusis the separation distance between the hole and electron. Due to 3 dimensional confinement effects, quantised energy levels are produced in the filled low energy valence band and in the empty conduction band of the quantum dots which is very unlike bulk semiconductors. The energy gap between the conduction and valance band varies with the size of the quantum dot which explains the tunable emissions (colour) when excited. Additionally, alloyed quantum dots can be further tuned because the bandgap is approximately equal to the weighted average of the composite semiconductor material. Quantum dots excited in the near-infrared are expected to be revolutionary in biomedical imaging. There has been concerns about the stability and toxicity, as many quantum dots lose luminescence intensity when exposed to light/air/oxygen/water and they are generally composed of heavy metal materials.

Upconversion Nanomaterials

Upconversion nanomaterials consist of two parts, first the host dielectric lattice (e.g., NaYF4) with one or more guest trivalent lanthanide (atomic numbers 5771) ions (e.g., Er3+, Yb3+). Upconversion is an anti-stokes process, two or more lower energy photons are absorbed (either simultaneously or stepwise) via long-lived real electronic states of the lanthanide dopant and a higher energy photon is emitted. The lanthanide element has a specific electronic configuration with energy levels which is usually independent of the host material type, the nanoparticle shape and its size.

Electrons are arranged in shells around an atoms nucleus, where the closest electrons to the nucleus have the lowest energy. Each shell can hold a certain number of electrons (principal quantum number) the first shell (1) can hold 2 electrons, the second (2) 8 and the third (3) 18. Within these shells are subshells (defined by theazimuthal quantum number) and are labelled s,p,d or f which can hold 2,6,10 or 14 electrons respectively.

In the case of upconversion, the 5s and 5p shells are full whereas the 4f-4f shells are not. But, because 5s and 5p are full they shield the 4f-4f shells which allows sharp line-like luminescence, i.e. the luminescencepeak is not broad. This luminescence is also resistant to photobleaching, high photostability and are nonblinking, which of course is beneficial over fluorescent molecules which experience high levels of degradation. Through careful design, upconversion nanomaterials can display a variety of emission and excitation wavelengths from UV to NIR.

These upconversion nanoparticles can be incorporated with photosensitizers to produce reactive oxygen species which generally require activation by UV light. This therapy procedure is calledPhotodynamic therapyand can be used for treating a wide range of medical conditions including malignant cancers and acne. Upconverison nanomaterials also have applications in multimodal imaging through the use of specific dopants high atomic number dopants for computed tomography (CT) imaging, radioisotopes for single-photon emission tomography (SPECT) imaging or positron emission tomography(PET) imaging.

MagneticNanomaterials

At the nanoscale, certain magnetic materials below a specific size exhibit a special form of magnetism called superparamagnetism. Superparamagnetic nanoparticles behave as single domain paramagnets when under an external magnetic field but once the field is removed there is no residual magnetisation. Typically, these materials areIron oxide nanoparticles. Additionally, these nanomaterials tend to be non-toxic and can be readily coated with molecules for further functionalization. These nanoparticles are commonly used as MRI contrast agentsinmagnetic resonance imaging (MRI).Furthermore, magnetic nanoparticles can be used in nanotherapy either through magnetic-field-directed drug delivery or through magnetic hyperthermia which involves localized heating of diseased tissues and therefore, cell death.

Silica Nanoparticles

Silica is a highly biocompatible biomaterial which is often used in nanomedicine.

Mesoporous silica nanoparticles are silica nanoparticles which have been template-patterned to have pores throughout the particle. This is done through the use of surfactants likeCetrimonium bromide(CTAB), which is extracted after synthesis leaving holes where the CTAB once was. In these pores, water insoluble materials can be added, such as drugs for chemotherapy, dyes for imaging or even small nanoparticles. These pore sizes can be controlled to encapsulate various sizes of biomolecules. Silica is often used to coat nanoparticles to achieve biocompatibility and to simplify further functionalisation.

PlasmonicNanomaterials

Now, saving the best for last plasmonic nanoparticles.

Plasmonic nanoparticles consist of noble metals like gold, silver, copper and aluminium. At the nanoscale, these materials can supportLocalized surface plasmons, which is a collective oscillation of the free surface electrons at the interface between the nanomaterial and the surrounding dielectric medium when resonance occurs between the natural resonant frequency of the surface electrons and the frequency of the incident light photons. The LSPR can be tuned with the material, size and shape of the nanoparticle.

Plasmonic nanoparticles can scatter and absorb light, for example, for smaller nanoparticles absorption tends to dominate (more light is absorbed which is generally converted to heat energy) and for larger nanoparticles scattering tends to dominate (which is exploited in bioimaging). For this reason, smaller nanoparticles are often used in photothermal therapy. InPhotothermal therapy, plasmonic nanoparticles accumulate in diseased tissues then are irradiated with resonant light, the nanoparticles absorb this light energy and convert it to heat energy, resulting in localised heating of the damaged tissue. This localised heating causes cell death, thus this therapy can be used for cancerous tumors. This heating can be visualised using thermographical measurements or using a dark field microspectroscope, plasmon scattering can be used in medical imaging. Please giveBiomedical applications of plasmon resonant metal nanoparticles, Liao et. al.a read for additional information.

Like Loading…

Read the rest here:
What is Nanomedicine? The future of medicine.

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Conferences | NanoPharma Conferences 2018 …

Sessions/Tracks

ConferenceSeries Ltdis a renowned organization that organizes highly notableconferencesthroughout the globe. Currently we are bringing forth14thInternational Conference and Exhibition onNanomedicine andPharmaceutical Nanotechnology(NanoMed 2018)scheduled to be held duringApril 16-18, 2018atAmsterdam, Netherlands.The conferenceinvites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Clinical Trials.

The main theme of the conference is Emerging Importance of Nanotechnology to Drive the Pharma Industry.

ConferenceSeries Ltdorganizes aconference seriesof 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientificsocietiesand publishes 700+Open access Journalswhich contains over 50000 eminent personalities, reputed scientists as editorial board members.

14thInternational Conference and Exhibition onNanomedicineandPharmaceutical Nanotechnologyaims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Nanotechnology and Nanomedicine. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields ofNanotechnologyand Nanomedicine.

Medicinehas developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields ofengineering, physics,chemistryandbiotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond.

As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This conference will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches.

Nanomedicineis a uniquely addressing the important challenges and advances in medicalnanoscale-structured materialand devices,biotechnology devicesand molecular machine systems andnanorobotics. NanoMed 2018 is a valuable information source for all players in the field academic, industrial and clinical researchers, pharmaceutical and biotechnology companies,regulatory authoritiesand others across the scientific community.

Track 1:NanomedicineandBiomedical Applications:

Nanomedicineis simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use ofnanoparticlesto improve the behaviour ofdrug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian andbreast cancer, kidney disease, fungal infections,elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain,asthmaand emphysema. The nanomedicines that are currently available are overcoming some of the difficulties experienced by normal medical approaches in delivering the benefit from thedrug moleculesused. In some cases the drugs have very little solubility in water and the human body struggles to absorb enough to treat the condition. In other cases, the drug molecule is absorbed well but the body removes the drug before it has had long enough to provide a benefit. Drugs may lead to side-effects due to poor delivery at the actual site of disease. For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be caused. Nanomedicines therefore can play an important role in ensuring enough of the drug enters the body, that drug that does enter stays in the body for long periods and is targeted specifically to the areas that need treatment.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 2:Design of Nanodrugs

To date, variousnanodrug systemshave been developed for different routes of administration, which include dendrimers,nanocrystals, emulsions, liposomes, solid lipid nanoparticles, micelles, and polymeric nanoparticles. Nanodrug systems have been employed to improve the efficacy, safety, physicochemical properties, and pharmacokinetic/pharmacodynamic profile of pharmaceutical substances. In particular, functionalized nanodrug systems can offer enhancedbioavailabilityof orally taken drugs, prolonged half-life of injected drugs (by reducing immunogenicity), andtargeted delivery to specific tissues. Thus,nanodrug systemsmight lower the frequency of administration while providing maximized pharmacological effects and minimized systemic side effects, possibly leading to better therapeutic compliance and clinical outcomes. In spite of these attractive pharmacokinetic advantages, recent attention has been drawn to the toxic potential of nanodrugs since they often exhibit in vitro and in vivo cytotoxicity, oxidative stress, inflammation, and genotoxicity

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 3:Design & Characterization of Nanosystems

Micro andNanosystemspublishes significant original work, topical reviews and guest edited issues ranging from technologies and systems to product innovation and new manufacturing processes with features at the micro and nanoscale. Applications for micro and nanosystems in areas such as health, environment, food, security and consumer goods are covered. The topics to be addressed include Lab-on-a-chip,microfluidics, nano-biotechnology, micro andnanomanufacturing, printed electronics and MEMS.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 4:NanomedicineandNanotechnology

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use ofnanoscale materials, such as biocompatible nanoparticles andnanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism.Nanotechnologyhas many definitions but in general it is the use and application of materials with sizes in the nanometre range. Just as a millimetre is one-thousandth of a metre, a nanometre is one-millionth of a millimetre. In more understandable terms, a human hair is approximately 80,000 nanometres in diameter and the growing science and industry of nanotechnology utilises materials below 1000 nanometres. Benefits of working at this very small scale have been seen for many years over such diverse areas as electronics and energy storage to sunscreens and food packaging.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 5:Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnologydeals with emerging new technologies for developing customized solutions fordrug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptors signaling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy asnanomaterials, and as devices likedrug delivery, diagnostic, imaging and biosensor.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 6:Synthesis of NanoparticlesforDrug Delivery

Synthesizingnanoparticlesfor pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such asliposomesare used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain; 10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany; 23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 7:Regenerative MedicineandTissue Engineering

Tissue engineeringis a branch of regenerative medicine, itself a branch ofbiomedical engineering. Tissue engineering andregenerative medicineare concerned with the replacement or regeneration of cells, tissues (the focus of tissue engineers) or organs to restore normal biological function.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 8:Drug Delivery Research

Drug deliveryis an essential part ofpharmaceutical sciencesthat should be taken into account early in thedrug discoveryand development process. A drug that cannot be delivered to its site of action is essentially useless. Drug delivery is affected by the physico-chemical properties of the drug and formulation and the interplay of these factors with the transport, binding, and metabolism of the drug in the body. New tools are needed to accurately predict delivery properties of the compounds early during drug discovery, so that the best compounds can be identified for clinical studies. Another class of tools includes the delivery methods that facilitate delivery of hard-to-deliver compounds to the appropriate target sites. Delivery of gene-based drugs (DNA, oligonucleotides, siRNA) and proteins is a major challenge in pharmaceutical science. Nanotechnology can be used to improve drug delivery in these difficult cases. The development and use of nanoparticles in theformulationof these types of drugs is a major focus at CDR, and we welcome productive industrial partnerships to develop these tools for translational use.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 9:Novel Drug Delivery Systems

Novel Drug delivery systemis the advancedrug delivery systemwhich improvedrug potency,control drug releaseto give a sustained therapeutic effect, provide greater safety, finally it is to target a drug specifically to a desired tissue.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 10:Smart Drug Delivery Technology

With the unprecedented progresses ofbiomedical nanotechnologyduring the past few decades, conventionaldrug delivery systems(DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. Benefiting from the response to specific internal or external triggers, those well-defined nanoplatforms can increase the drug targeting efficacy, in the meantime; reduce side effects/toxicities of payloads, which are key factors for improving patient compliance. In academic field, variety of smart DDSs have been abundantly demonstrated for various intriguing systems, such as stimuli-responsivepolymeric nanoparticles, liposomes, metals/metal oxides, and exosomes.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 11:Nano Pharmaceuticals

Nanopharmaceuticalsoffer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nanopharmaceuticals represent an emerging field where the sizes of thedrug particleor a therapeutic delivery system work at thenanoscale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via nanopharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. In todays world economy, apharmaceutical industryfaces enormous pressure to deliver high-quality products to patients while maintaining profitability. Thereforepharmaceutical companiesare applying nanotechnology to enhance or supplement drug target discovery anddrug delivery. Nanopharmaceutical reduces the cost of drug discovery, design & development and enhances the drug delivery process. This results in the improvedResearch & Developmentsuccess rate which enables faster introduction of new, cost-effective products to the marketplace.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

Related Societies:

Societies in USA:American Academy of Nanomedicine,Nano Canadian Society,American Nano Society,American Society for Nanomedicine,Society for Personalized Nano MedicineInternational Association of NanotechnologyandGraphene Stakeholders Association

Societies in Europe:Nanotechnology Industries Association,Royal Microscopical Society,Royal Society – Nanotechnology and Nanoscience,British Society for Nanomedicine,European Society for Nanomedicine,French Society for Nanomedicine,European NanoBusiness Association,European Society for Precision Engineering and Nanotechnology,Czech Nanotechnology Industries AssociationandErwin Schrdinger Society for Nanosciences

Societies in Asia:National Center for Nanoscience and Technology,Indian Society for Nanomedicine,Nano Technology Research AssociationandIndian Society of Nanomedicine.

Track 12:Nanobiotechnology

Nanobiotechnology,bionanotechnology, and nanobiology are terms that refer to the intersection of nanotechnology andbiology. This discipline helps to indicate the merger of biological research with various fields of nanotechnology. Concepts that are enhanced throughnanobiologyinclude:nanodevices(such asbiological machines), nanoparticles, and nanoscale phenomena that occurs within the discipline of nanotechnology. This technical approach to biology allows scientists to imagine and create systems that can be used forbiological research. Biologically inspired nanotechnology uses biological systems as the inspirations for technologies not yet created.

Related Conferences:NanoPharma Conferences|Nanomedicine Symposium|Nanomedicine Conferences|Nanomedicine Meetings|Nanomedicine Congress|Nanopharma Meetings

12thPharmaceutical Sciences andPharma Industry ConferenceFebruary 26- 27 2018,London, UK; 7thEuropeanBiosimilars Conference, April 26-27, 2018, Rome,Italy; 13thEuropean Pharma ConferencesMay 07-09, 2018 at Frankfurt,Germany; 4thMarine Drugs andNatural Products Conferences, June 11-13, 2018 atRome, Italy; 9thGlobal ExpertsMeeting on Neuropharmacology, June 18-19, 2018 atParis, France; 4thConference onAntibiotics Conference; June 14-15, 2018,Barcelona, Spain;Nanomedicine Conferences 2018 USA;10thPharmacology Conferencesduring July 30-August 01, 2018 at Barcelona,Spain; 8thEnvironmental Chemistry Conference, September 20-22, 2018 Berlin,Germany;Nanomedicine Conferences 2018 Asia;23rdConference on Nanomaterialsand Nanotechnology, March 15-16, 2018 at London,UK; 3rdConference On Nanomedicine, Drug Delivery, and Tissue Engineering, April 10 – 12, 2018 at Budapest,Hungary;World Congress on Nanotechnologyand Material Science, April 16-18, 2018 at Valencia,Spain; Conference onEmerging Trends in Materials Science and Nanotechnology, April 26-27, 2018 at Rome,Italy; 24thWorld Nano ConferenceMay 07-08, 2018 at Rome,Italy;Conference on Nanoscience& technology, May 21-22, 2018 at New York,USA; 20thConference on Nanotechnologyand Nanomedicine, July 9 – 10, 2018 at Prague, Czechia;Nanomedicine Conferences 2018 Asia;Conference on Nanotech & Nanobiotechnology, July 12-13, 2018 at Paris,France; 20thConference on Nanoscience, Nanotechnology and Advanced Materials, August 13 – 14, 2018 at Venice,Italy.

See the original post here:
Nanomedicine Conferences | NanoPharma Conferences 2018 …

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine – Overview

The program began in 2005 with a national network ofeight Nanomedicine Development Centers. Now, in the second half of this 10-year program, the four centers best positioned to effectively apply their findings to translational studies were selected to continue receiving support.

Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease or repairing damaged tissues, such as bone, muscle, or nerve. A nanometer is one-billionth of a meter, too small to be seen with a conventional lab microscope. It is at this size scale about 100 nanometers or less that biological molecules and structures operate in living cells.

The NIH vision for Nanomedicine is built upon the strengths of NIH funded researchers in probing and understanding the biological, biochemical and biophysical mechanisms of living tissues. Since the cellular machinery operates at the nanoscale, the primary goal of the program – characterizing the molecular components inside cells at a level of precision that leads to re-engineering intracellular complexes – is a monumental challenge.

The teams selected to carry out this initiative consist of researchers with deep knowledge of biology and physiology, physics, chemistry, math and computation, engineering, and clinical medicine. The choice and design of experimental approaches are directed by the need to solve clinical problems (e.g., treatment of sickle cell disease, blindness, cancer, and Huntingtons disease). These are very challenging problems, and great breakthroughs are needed to achieve the goals within the projected 10 year timeframe. The initiative was selected for the NIH Roadmap (now Common Fund) precisely because of the challenging, high risk goals, and the NIH team is working closely with the funded investigators to use the funds and the intellectual resources of the network of investigators to meet those challenges.

10 Year Program Design High Risk, High Reward

The Centers were funded with the expectation that the first half of the initiative would be more heavily focused on basic science with increased emphasis on application of this knowledge in the second five years. This was a novel, experimental approach to translational medicine that began by funding basic scientists interested in gaining a deep understanding of an intracellular nanoscale system and necessitated collaboration with clinicians from the outset in order to properly position work at the centers so that during the second half of the initiative, studies would be applied directly to medical applications. The program began witheight Nanomedicine Development Centers(NDCs), and four centers remain in the second half of the program.

Clinical Consulting Boards (CCBs)

The program has establishedClinical Consulting Boards (CCBs)for each of the continuing centers. These boards consist of at least three disease-specific clinician-scientists who are experts in the target disease(s). The intent is for CCBs to provide advice and insight into the needs and barriers regarding resource and personnel allocations as well as scientific advice as needed to help the centers reach their translational goals. Each CCB reports directly to the NIH project team.

Translational Path

In 2011, the PIs of the NDCs worked with their CCBs to precisely define their translational goals and the translational research path needed to reach those goals by the end of the initiative in 2015. To facilitate this, the NIH project team asked them to developcritical decision pointsalong their path. These critical decision points differ from distinct milestones because they may be adjusted based on successes, challenges, barriers, and progress. Similarly, the timing of these decision points may be revised as the centers progress. Research progress and critical decision points are revisited several times a year by the CCB and the NIH team, and when a decision point is reached, next steps are re-examined for relevance, feasibility and timing.

Transition plan

Throughout the program, various projects have been spun off of work at all the centers and most have received funding from other sources. This was by design as work at each center has been shifting from basic science to translational studies. Centers will not be supported by the common fund after 10 years. It is expected that work at the centers will be more appropriately funded by other sources. Pre-clinical targets will likely be developed, and the work at each center will be focused on a specific disease so the work will need to transition out of the experimental space of the common fund.

Support for the NIH Nanomedicine Initiative is provided by the NIH Common Fund, and a team of staff members from across the NIH oversees the program. You may direct questions or comments on the NIH Nanomedicine Initiative to Dr. Richard S. Fisher, Nanomedicine Project Team Leader (nano@nih.gov).

More here:
Nanomedicine – Overview

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine – Overview – NIH Common Fund

Background

Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease or repairing damaged tissues, such as bone, muscle, or nerve. A nanometer is one-billionth of a meter, too small to be seen with a conventional lab microscope. It is at this size scale about 100 nanometers or less that biological molecules and structures operate in living cells.

The NIH vision for Nanomedicine is built upon the strengths of NIH funded researchers in probing and understanding the biological, biochemical and biophysical mechanisms of living tissues. Since the cellular machinery operates at the nanoscale, the primary goal of the program – characterizing the molecular components inside cells at a level of precision that leads to re-engineering intracellular complexes – is a monumental challenge.

The teams selected to carry out this initiative consist of researchers with deep knowledge of biology and physiology, physics, chemistry, math and computation, engineering, and clinical medicine. The choice and design of experimental approaches are directed by the need to solve clinical problems (e.g., treatment of sickle cell disease, blindness, cancer, and Huntingtons disease). These are very challenging problems, and great breakthroughs are needed to achieve the goals within the projected 10 year timeframe. The initiative was selected for the NIH Roadmap (now Common Fund) precisely because of the challenging, high risk goals, and the NIH team is working closely with the funded investigators to use the funds and the intellectual resources of the network of investigators to meet those challenges.

10 Year Program Design High Risk, High Reward

The Centers were funded with the expectation that the first half of the initiative would be more heavily focused on basic science with increased emphasis on application of this knowledge in the second five years. This was a novel, experimental approach to translational medicine that began by funding basic scientists interested in gaining a deep understanding of an intracellular nanoscale system and necessitated collaboration with clinicians from the outset in order to properly position work at the centers so that during the second half of the initiative, studies would be applied directly to medical applications. The program began with eight Nanomedicine Development Centers (NDCs), and four centers remain in the second half of the program.

Clinical Consulting Boards (CCBs)

The program has established Clinical Consulting Boards (CCBs) for each of the continuing centers. These boards consist of at least three disease-specific clinician-scientists who are experts in the target disease(s). The intent is for CCBs to provide advice and insight into the needs and barriers regarding resource and personnel allocations as well as scientific advice as needed to help the centers reach their translational goals. Each CCB reports directly to the NIH project team.

Translational Path

In 2011, the PIs of the NDCs worked with their CCBs to precisely define their translational goals and the translational research path needed to reach those goals by the end of the initiative in 2015. To facilitate this, the NIH project team asked them to develop critical decision points along their path. These critical decision points differ from distinct milestones because they may be adjusted based on successes, challenges, barriers, and progress. Similarly, the timing of these decision points may be revised as the centers progress. Research progress and critical decision points are revisited several times a year by the CCB and the NIH team, and when a decision point is reached, next steps are re-examined for relevance, feasibility and timing.

Transition plan

Throughout the program, various projects have been spun off of work at all the centers and most have received funding from other sources. This was by design as work at each center has been shifting from basic science to translational studies. Centers will not be supported by the common fund after 10 years. It is expected that work at the centers will be more appropriately funded by other sources. Pre-clinical targets will likely be developed, and the work at each center will be focused on a specific disease so the work will need to transition out of the experimental space of the common fund.

Support for the NIH Nanomedicine Initiative is provided by the NIH Common Fund, and a team of staff members from across the NIH oversees the program. You may direct questions or comments on the NIH Nanomedicine Initiative to Dr. Richard S. Fisher, Nanomedicine Project Team Leader (nano@nih.gov).

Excerpt from:
Nanomedicine – Overview – NIH Common Fund

Recommendation and review posted by Alexandra Lee Anderson

What is Nanomedicine – The British Society for Nanomedicine

Warning: include() [function.include]: Failed opening ‘/home/bsnm/public_html/manager/includes/sniff/session.php’ for inclusion (include_path=’.:/usr/lib/php’) in /home/bsnm/public_html/index.php on line 3

Warning: Cannot modify header information – headers already sent by (output started at /home/bsnm/public_html/index.php:3) in /home/bsnm/public_html/index.php on line 76

Warning: Cannot modify header information – headers already sent by (output started at /home/bsnm/public_html/index.php:3) in /home/bsnm/public_html/index.php on line 77

Warning: session_start() [function.session-start]: Cannot send session cookie – headers already sent by (output started at /home/bsnm/public_html/index.php:3) in /home/bsnm/public_html/manager/includes/config.inc.php on line 108

Warning: Cannot modify header information – headers already sent by (output started at /home/bsnm/public_html/index.php:3) in /home/bsnm/public_html/manager/includes/config.inc.php on line 115Error

Read the rest here:
What is Nanomedicine – The British Society for Nanomedicine

Recommendation and review posted by Alexandra Lee Anderson

Global Nanomedicine Industry 2017 Market Growth, Trends and Demands Research Report – MENAFN.COM

(MENAFN Editorial) iCrowdNewswire – Sep 4, 2017

The Global Nanomedicine Market 2017 Industry Research Report’ report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the Global major industry players in detail.

The Global Nanomedicine Market Research Report 2017 renders deep perception of the key regional market status of the Nanomedicine Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, #China and Japan.

Complete report on Nanomedicine market report spread across 116 pages, profiling 12 companies and supported with tables and figuresavailable @

The report on ‘Global Nanomedicine Market is a professional report which provides thorough knowledge along with complete information pertaining to the Nanomedicine industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc.

The potential of this industry segment has been rigorously investigated in conjunction with primary market challenges. The present market condition and future prospects of the segment has also been examined. Moreover, key strategies in the market that includes product developments, partnerships, mergers and acquisitions, etc., are discussed. Besides, upstream raw materials and equipment and downstream demand analysis is also conducted.

Report Includes:-

The report cloaks the market analysis and projection of ‘Nanomedicine Market on a regional as well as global level. The report constitutes qualitative and quantitative valuation by industry analysts, first-hand data, assistance from industry experts along with their most recent verbatim and each industry manufacturers via the market value chain. The research experts have additionally assessed the in general sales and revenue generation of this particular market. In addition, this report also delivers widespread analysis of root market trends, several governing elements and macro-economic indicators, coupled with market improvements as per every segment.

For any Inquire before buying @

Global Nanomedicine market competition by top manufacturers/players, with Nanomedicine sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including: GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., SigmaTau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A

The report is generically segmented into six parts and every part aims on the overview of the Nanomedicine industry, present condition of the market, feasibleness of the investment along with several strategies and policies. Apart from the definition and classification, the report also discusses the analysis of import and export and describes a comparison of the market that is focused on the trends and development. Along with entire framework in addition to in-depth details, one can prepare and stay ahead of the competitors across the targeted locations. The fact that this market report renders details about the major market players along with their product development and current trends proves to be very beneficial for fresh entrants to comprehend and recognize the industry in an improved manner. The report also enlightens the productions, sales, supply, market condition, demand, growth, and forecast of the Nanomedicine industry in the global markets.

Buy a copy of this report @

Every region’s market has been studied thoroughly in this report which deals with the precise information pertaining to the Marketing Channels and novel project investments so that the new entrants as well as the established market players conduct intricate research of trends and analysis in these regional markets. Acknowledging the status of the environment and products’ up gradation, the market report foretells each and every detail.So as to fabricate this report, complete key details, strategies and variables are examined so that entire useful information is amalgamated together for the understanding and studying the key facts pertaining the global Nanomedicine Industry. The production value and market share in conjunction with the SWOT analysis everything is integrated in this report.

Table of Contents

1 Nanomedicine Market Overview 2 Global Nanomedicine Market Competition by Manufacturers 3 Global Nanomedicine Capacity, Production, Revenue (Value) by Region (2011-2016) 4 Global Nanomedicine Supply (Production), Consumption, Export, Import by Regions (2011-2016) 5 Global Nanomedicine Production, Revenue (Value), Price Trend by Type 6 Global Nanomedicine Market Analysis by Application 7 Global Nanomedicine Manufacturers Profiles/Analysis

8 Nanomedicine Manufacturing Cost Analysis 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 10 Marketing Strategy Analysis, Distributors/Traders 11 Market Effect Factors Analysis 12 Global Nanomedicine Market Forecast (2016-2021) 13 Research Findings and Conclusion

About Us

Deep Research Reportsis digital database of syndicated market reports for global and #China industries. These reports offer competitive intelligence data for companies in varied market segments and for decision makers at multiple levels in these organizations. We provide 24/7 online and offline support to our customers.

Connect us

Hrishikesh Patwardhan

Corporate Headquarters

2nd floor, metropole,

Next to inox theatre,

Bund garden road,Pune-411001.

1 888 391 5441

MENAFN0509201700703403ID1095819074

Read the original here:
Global Nanomedicine Industry 2017 Market Growth, Trends and Demands Research Report – MENAFN.COM

Recommendation and review posted by Alexandra Lee Anderson

Nanobiotechnology Applications, Markets and Companies, 2017-2021 & 2026 – GlobeNewswire (press release)

Dublin, Sept. 07, 2017 (GLOBE NEWSWIRE) — The “Nanobiotechnology Applications, Markets and Companies” report from Jain PharmaBiotech has been added to Research and Markets’ offering.

The report starts with an introduction to various techniques and materials that are relevant to nanobiotechnology. It includes some of the physical forms of energy such as nanolasers. Some of the technologies are scaling down such as microfluidics to nanofluidic biochips and others are constructions from bottom up. Application in life sciences research, particularly at the cell level sets the stage for role of nanobiotechnology in healthcare in subsequent chapters.

An increasing use of nanobiotechnology by the pharmaceutical and biotechnology industries is anticipated. Nanotechnology will be applied at all stages of drug development – from formulations for optimal delivery to diagnostic applications in clinical trials. Many of the assays based on nanobiotechnology will enable high-throughput screening. Some of nanostructures such as fullerenes are themselves drug candidates as they allow precise grafting of active chemical groups in three-dimensional orientations. The most important pharmaceutical applications are in drug delivery. Apart from offering a solution to solubility problems, nanobiotechnology provides and intracellular delivery possibilities. Skin penetration is improved in transdermal drug delivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices with autonomous operation guided by the needs.

Nanomedicine is now within the realm of reality starting with nanodiagnostics and drug delivery facilitated by nanobiotechnology. Miniature devices such as nanorobots could carry out integrated diagnosis and therapy by refined and minimally invasive procedures, nanosurgery, as an alternative to crude surgery. Applications of nanobiotechnology are described according to various therapeutic systems. Nanotechnology will markedly improve the implants and tissue engineering approaches as well. Of the over 1,000 clinical trials of nanomedicines, approximately 100 are selected and tabulated in major therapeutic areas. Other applications such as for management of biological warfare injuries and poisoning are included. Contribution of nanobiotechnology to nutrition and public health such as supply of purified water are also included.

Future nanobiotechnology markets are calculated on the basis of the background markets in the areas of application and the share of this market by new technologies and state of development at any given year in the future. This is based on a comprehensive and thorough review of the current status of nanobiotechnology, research work in progress and anticipated progress. There is definite indication of large growth of the market but it will be uneven and cannot be plotted as a steady growth curve. Marketing estimates are given according to areas of application, technologies and geographical distribution starting with 2016. The largest expansion is expected between the years 2021 and 2026.

Profiles of 252 companies, out of over 500 involved in this area, are included in the last chapter along with their 183 collaborations.The report is supplemented with 51 Tables, 31 figures and 800 references to the literature.

Key Topics Covered:

Part I: Applications & Markets

1. Introduction

2. Nanotechnologies

3. Nanotechnologies for Basic Research Relevant to Medicine

4. Nanomolecular Diagnostics

5. Nanopharmaceuticals

6. Role of Nanotechnology in Biological Therapies

7. Nanodevices & Techniques for Clinical Applications

8. Nanooncology

9. Nanoneurology

10. Nanocardiology

11. Nanopulmonology

12. Nanoorthopedics

13. Nanoophthalmology

14. Nanomicrobiology

15. Miscellaneous Healthcare Applications of Nanobiotechnology

16. Nanobiotechnology and Personalized Medicine

17. Nanotoxicology

18. Ethical and Regulatory Aspects of Nanomedicine

19. Research and Future of Nanomedicine

20. Nanobiotechnology Markets

21. References

Part II: Companies

22. Nanobiotech Companies

For more information about this report visit https://www.researchandmarkets.com/research/xnnnck/nanobiotechnology

Read more from the original source:
Nanobiotechnology Applications, Markets and Companies, 2017-2021 & 2026 – GlobeNewswire (press release)

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Research Journal

Nanomedicine Research Journal (Abbreviation: Nanomed Res J)

is an international, open access, peer-reviewed, electronic and print quarterly publication released by the Iranian Society of Nanomedicine (ISNM). Nanomedicine Research Journal publishes original research articles, review papers, mini review papers, case reports and short communications covering a wide range of field-specific and interdisciplinary theoretical and experimental results related to applications of nanoscience and nanotechnology in medicine including, but not limited to, diagnosis, treatment, monitoring, prediction and prevention of diseases, tissue engineering, nano bio-sensors, functionalized carriers and targeted drug delivery systems.

* Publication process of manuscripts submitted to Nanomed Res J is free of charge.

To see Acceptance timeline Please follow the link below:

Acceptance Timeline Diagram

About the publisher

Founded in 2011 by the leading ofSchool of Advanced Technologies in medicine (SATiM),Tehran University of Medical Sciences (TUMS) and Iran Nanotechnology Initiative Council, the Iranian Society of Nanomedicine (ISNM) attempts to promote and develop medical nanotechnology in Iran. For more information about the publisher, please visit us at http://isnm.ir/en/.

Here is the original post:
Nanomedicine Research Journal

Recommendation and review posted by Alexandra Lee Anderson